Dossier
John Wiley & Sons
Coverage of John Wiley & Sons in the Nexus archive.
- Alzheimer's Paper Retracted; MS Before Epstein-Barr Infection; Brain Aging Map
A 2024 report detailing a severe Alzheimer's disease patient who improved after receiving an intravenous mesenchymal stem cell transplant was retracted by the journal Case Reports in Neurological Medicine and its publisher, John Wiley & Sons. The retraction follows the study's publication, which had highlighted potential therapeutic advancements in Alzheimer's treatment.